Skip to main content

C-RAD Financial Reports during the Fiscal Year 2015

Press release 2015-2-3
The following dates for the publication of the Interim reports, Half-Year
Report as well as for the Year-End Report for the fiscal year 2015 have been
defined. The reports will be published at 3:00 pm on the respective date:

Press release 2015-2-3

The following dates for the publication of the Interim reports, Half-Year Report as well as for the Year-End Report for the fiscal year 2015 have been defined. The reports will be published at 3:00 pm on the respective date:

 

Interim Report Q1 2015:    May 8th 2015

Half-Year Report:               August 14th 2015

Interim Report Q3 2015:    November 6th 2015

Year-End Report                February 5th 2016

 

The AGM will take place on April 16th 2015.

About C-RAD

C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. End users are radiation therapy clinics worldwide. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. Employees currently number 30. C-RAD’s business originates from research and development at Karolinska Institutet in Solna, Sweden. Sales of the company’s first product, the C-RAD SentinelTM, started in 2007. Cooperation agreements have been signed with Elekta (Sweden), Varian (USA) and IBA (Belgium). C-RAD is represented by distributors specialized in radiation therapy on major markets. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. C-RAD holds 29% of the laser company Cyrpa with an option to acquire the remaining 71%. C-RAD AB is listed – since December 2014 – on NASDAQ Stockholm.

For more information on C-RAD, please visit www.c-rad.com.

 

For further information:

Tim Thurn, CEO C-RAD AB, Phone +46-18-666931, E-mail investors@c-rad.com

Close Menu